Skip to main content
. Author manuscript; available in PMC: 2022 Jul 21.
Published in final edited form as: Adv Exp Med Biol. 2022;1376:135–149. doi: 10.1007/5584_2021_657

Fig. 1. The regenerative treatments of sickle cell disease.

Fig. 1

The hematopoietic stem cells derived from sickle cell patients can be differentiated into improved hemoglobin types and retransfused into the patient to replace the sickle cell.